Trial of Orca-T Following Reduced Intensity or Nonmyeloablative Conditioning in Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome
Orca Biosystems, Inc.
Orca Biosystems, Inc.
National Institutes of Health Clinical Center (CC)
Eli Lilly and Company
British Columbia Cancer Agency
Brigham and Women's Hospital
Meryx, Inc.
Qilu Pharmaceutical Co., Ltd.
Plus Therapeutics
Servier
University Hospital, Antwerp
AO GENERIUM
Odense University Hospital
Corcept Therapeutics
University of Aarhus
Umm Al-Qura University
Pfizer
Celgene
Zealand University Hospital
Yale University
Université de Sherbrooke
University of Kansas Medical Center
BBB-Therapeutics B.V.
Assistance Publique - Hôpitaux de Paris
Cedar Associates LLC
AVEO Pharmaceuticals, Inc.
Tracon Pharmaceuticals Inc.